Familial amyotrophic lateral sclerosis is an inherited form of a devastating neurological disease that causes progressive muscle weakness and paralysis. Unlike the more common sporadic form of ALS, familial cases run in families and are passed down through genetic mutations, often affecting multiple family members across generations.

Understanding Familial Amyotrophic Lateral Sclerosis

Familial amyotrophic lateral sclerosis, often called familial ALS or fALS, represents a genetic form of a progressive disease that attacks the nerve cells responsible for controlling voluntary muscle movement. These specialized nerve cells, known as motor neurons, extend from the brain and spinal cord to muscles throughout the body. When these neurons die, the brain can no longer initiate and control muscle movement, leading to progressive weakness, muscle wasting, and eventually paralysis.^[1]

The term “amyotrophic” comes from Greek, where “a” means no or negative, “myo” refers to muscle, and “trophic” means nourishment. Together, these components describe what happens in the disease: muscles receive no nourishment and begin to waste away. “Lateral” identifies the areas in the spinal cord where portions of the nerve cells that nourish muscles are located, and “sclerosis” refers to the scarring or hardening that develops as this area degenerates.^[14]

What distinguishes familial ALS from other forms is its inheritance pattern. While the disease causes the same devastating symptoms regardless of its origin, familial ALS results from specific genetic mutations passed from parents to their children. This genetic component means that multiple family members may develop the condition, often creating patterns of disease that can be traced through family trees.^[3]

Epidemiology

Familial ALS accounts for approximately five to ten percent of all ALS cases worldwide, with the remaining ninety to ninety-five percent classified as sporadic, meaning they occur in individuals without an apparent family history of the disease.^[2][4] This relatively small proportion translates to about five hundred to one thousand people diagnosed with familial ALS each year in the United States, out of the estimated five thousand total annual ALS diagnoses.^[3]

The prevalence of familial ALS varies significantly by geographic region and ethnic background. The distribution of specific genetic mutations differs across populations, creating distinct patterns of familial disease around the world. For instance, certain mutations in the SOD1 gene are more common in North America than in Europe or Asia. The A4V mutation in SOD1, which causes a particularly aggressive form of the disease, accounts for about half of all SOD1-related familial ALS cases in North America but is rarely found in other parts of the world.^[5]

The age at which symptoms first appear tends to be younger in familial ALS compared to sporadic cases. While sporadic ALS typically affects people in their late fifties or early sixties, familial ALS symptoms often emerge in people’s late forties or early fifties. Some families carry mutations that cause symptoms to appear even earlier, sometimes in childhood or the teenage years, though these cases are rare and represent a distinct form known as juvenile ALS.^[3]

Unlike some other neurological conditions that show a strong gender preference, familial ALS can affect both men and women, though the overall pattern of ALS diagnosis shows slightly higher rates in men. The disease does not discriminate based on race or ethnicity, though the specific genetic mutations causing familial ALS may be more prevalent in certain populations.^[4]

Causes

Familial ALS is caused by inherited genetic mutations that are passed down from parents to their children. Since the identification of SOD1 as the first gene linked to familial ALS in 1993, researchers have discovered more than ten genes associated with the disease, each playing a role in motor neuron function and survival.^[1]

The SOD1 gene was a groundbreaking discovery, marking the first time scientists could link a specific gene to ALS. This gene normally produces an enzyme called superoxide dismutase 1, which helps protect cells from damage caused by toxic molecules. When mutations occur in this gene, they result in a misfolded form of the protein that accumulates in motor neurons, disrupting cellular processes and ultimately leading to cell death. Mutations in SOD1 account for thirteen to twenty percent of familial ALS cases.^[6]

The C9orf72 gene represents the most common genetic cause of familial ALS, accounting for thirty to forty percent of cases in families with a history of the disease. This mutation involves an abnormal expansion of a repeated section of DNA within the gene, creating problems with protein production and cellular function.^[3]

Other significant genes linked to familial ALS include FUS (fused in sarcoma) and TARDBP, which encodes a protein called TDP-43. Both of these genes are involved in processing RNA, the molecular messenger that carries genetic instructions from DNA to the protein-making machinery of cells. When these genes are mutated, they disrupt normal RNA processing, leading to widespread problems in motor neurons.^[4]

In total, more than forty genes have been associated with ALS, though not all of these are common causes of the familial form. About seventy percent of familial cases involve gene changes, most often in the C9orf72, SOD1, TARDBP, and FUS genes. Even among sporadic cases, genetic factors may play a role, with five to ten percent showing gene changes that could contribute to disease development.^[4]

While researchers understand that these genetic mutations cause familial ALS, the exact mechanisms by which they lead to motor neuron death remain complex and likely involve multiple pathways. Environmental factors may also interact with genetic predisposition, though the primary driver in familial cases is the inherited mutation itself.^[7]

Risk Factors

The most significant risk factor for familial ALS is having a biological parent who carries a disease-causing genetic mutation. Unlike sporadic ALS, where risk factors remain poorly understood and often involve complex interactions between genetic susceptibility and environmental exposures, familial ALS follows predictable inheritance patterns determined by specific genes.^[5]

The majority of familial ALS follows an autosomal dominant inheritance pattern, which means that a person needs to inherit only one copy of the mutated gene from one parent to develop the disease. In these families, each child of an affected parent has a fifty percent chance of inheriting the mutation. This pattern is particularly common with mutations in genes like SOD1, C9orf72, FUS, and TARDBP. Having a parent, sibling, or other close relative with ALS significantly increases the risk of developing the condition if the familial form is present in the family.^[5]

Age represents another important consideration in familial ALS. While the condition can appear at various ages, including in childhood in rare juvenile forms, most people with familial ALS develop symptoms in their forties or fifties. This is earlier than sporadic ALS, which typically affects people in their sixties. The specific genetic mutation involved can influence the age of onset, with some mutations associated with earlier or later symptom development.^[3]

The severity and speed of disease progression can vary depending on the specific genetic mutation. For example, individuals with certain SOD1 mutations, such as the A4V variant common in North America, tend to experience a particularly aggressive form of the disease with rapid progression. In contrast, other mutations may be associated with slower progression over many years.^[5]

It is important to understand that not everyone who inherits a disease-causing mutation will necessarily develop ALS, though the vast majority will. Factors that might influence whether and when symptoms appear in mutation carriers remain an active area of research. Additionally, even within the same family carrying the same mutation, there can be variability in age of onset and disease progression, suggesting that other genetic or environmental factors may play modifying roles.^[10]

For individuals with a family history of ALS, genetic testing and counseling can help determine whether they carry a known mutation associated with the disease. This information can be valuable for family planning and for making decisions about participation in clinical trials aimed at preventing or delaying disease onset in mutation carriers.^[5]

Symptoms

The symptoms of familial ALS are essentially the same as those seen in sporadic ALS, though they may appear at a younger age. The disease begins gradually, often with symptoms so subtle that they may be overlooked or attributed to other causes. This early period can be frustrating for both patients and families as the signs of disease become slowly apparent.^[3]

The earliest symptoms typically involve muscle weakness or stiffness, most commonly starting in the arms, legs, or muscles involved in speaking and swallowing. A person might notice difficulty with fine motor tasks like buttoning shirts, using keys, or writing. In the legs, early symptoms might include tripping, difficulty climbing stairs, or a feeling of heaviness or stiffness when walking. These initial changes can be so gradual that weeks or months may pass before the person realizes something is wrong.^[4]

Muscle twitching, medically called fasciculations, is another common early sign. These involuntary twitches can occur in the hands, feet, shoulders, or tongue. While muscle twitching alone is not necessarily a sign of ALS and can occur in healthy people, persistent and widespread fasciculations combined with weakness should prompt medical evaluation.^[4]

As the disease progresses, muscle cramping becomes increasingly common. These cramps can be painful and may occur at rest or during activity. The affected muscles may also feel stiff, a condition called spasticity, which makes movement more difficult and can contribute to falls or difficulty with coordination.^[4]

Speech difficulties, called dysarthria, develop when the muscles controlling the tongue, throat, and voice box are affected. Speech may become slurred, slower, or more effortful. The voice may sound different, sometimes becoming hoarse or nasal in quality. As these muscles weaken further, speaking becomes increasingly difficult, eventually requiring alternative communication methods.^[3]

Swallowing problems, known as dysphagia, emerge as the muscles controlling swallowing weaken. This begins with difficulty swallowing certain foods, particularly dry or tough items, and progresses to problems with liquids and eventually all foods. Dysphagia can lead to unintentional weight loss and increased risk of choking. Many people with ALS eventually require a feeding tube to maintain adequate nutrition.^[3]

Drooling becomes problematic as the muscles controlling saliva management weaken. This occurs not because the body produces more saliva, but because the person has difficulty swallowing it normally. This symptom can be socially embarrassing and uncomfortable for many individuals.^[4]

Breathing difficulties develop as the muscles controlling respiration, including the diaphragm, weaken. Early respiratory symptoms might include shortness of breath during exertion, difficulty lying flat, or disturbed sleep due to breathing problems. As the disease progresses, breathing becomes increasingly labored, and most people eventually require mechanical ventilation support. Respiratory failure is the most common cause of death in ALS.^[3]

Fatigue is a pervasive symptom that affects nearly everyone with ALS. This exhaustion goes beyond normal tiredness and can be overwhelming, affecting the ability to complete daily activities even when muscle strength is still relatively preserved.^[4]

Some people with familial ALS, approximately twenty percent, also develop frontotemporal dementia, or FTD. This condition causes changes in personality, behavior, and language abilities. Affected individuals may become socially inappropriate, lose empathy, exhibit poor judgment, or develop compulsive behaviors. Communication abilities may decline beyond what would be expected from muscle weakness alone. When ALS and FTD occur together, the condition is called ALS-FTD.^[3]

An unusual symptom that can be distressing for patients and families is the development of inappropriate emotional expressions, sometimes called pseudobulbar affect. This involves sudden episodes of uncontrollable laughing or crying that don’t match the person’s actual emotional state. These episodes occur without the person feeling particularly happy or sad and can happen at socially inappropriate times.^[4]

Throughout the disease progression, ALS typically does not affect the senses, including the ability to feel, taste, smell, hear, or see. Bladder and bowel control usually remain intact, and sexual function is generally preserved. The mind often remains sharp even as physical capabilities decline, which can be particularly challenging for individuals as they remain fully aware while losing the ability to move and communicate.^[14]

Prevention

Because familial ALS is caused by inherited genetic mutations, there is currently no way to prevent the disease from developing in people who carry these mutations. Unlike some conditions where lifestyle modifications or environmental interventions can reduce risk, familial ALS follows its genetic programming once the mutation is inherited. However, there are important steps families can take to prepare for the possibility of disease and to maximize quality of life if symptoms develop.^[5]

Genetic testing represents the most important tool for families affected by familial ALS. Individuals with a family history of ALS can undergo genetic testing to determine whether they carry a known disease-causing mutation. This testing should always be accompanied by genetic counseling, which helps individuals understand the implications of test results, both positive and negative. Genetic counselors can explain inheritance patterns, discuss the likelihood of developing disease, and address concerns about family planning.^[5]

For people who test positive for a disease-causing mutation but do not yet have symptoms, participation in clinical trials may offer the best hope for prevention or delay of disease onset. Several studies are now enrolling pre-symptomatic carriers of mutations, particularly SOD1 mutations, to test whether treatments can prevent or postpone the development of symptoms. The ATLAS trial, for example, is studying whether the drug tofersen can benefit individuals with SOD1 mutations before they develop any signs of disease.^[8]

While there is no evidence that specific lifestyle changes can prevent familial ALS in mutation carriers, maintaining overall health may optimize physical function and well-being. Regular exercise, a balanced diet, avoiding smoking, and limiting alcohol consumption are generally recommended for overall health, though their specific effects on ALS risk or progression remain uncertain.^[4]

For individuals planning to have children who are concerned about passing on a genetic mutation, several reproductive options exist. Pre-implantation genetic diagnosis, used in conjunction with in vitro fertilization, allows testing of embryos for known familial ALS mutations before pregnancy is established. Only embryos without the mutation would be implanted. Other options include using donor eggs or sperm, adoption, or choosing not to have biological children. These are deeply personal decisions that benefit from discussion with genetic counselors and reproductive specialists.^[5]

Early detection and intervention, while not preventing the disease, can improve outcomes and quality of life. People with known genetic mutations should maintain regular contact with neurologists familiar with ALS, even before symptoms appear. This allows for prompt recognition of any changes and rapid initiation of supportive therapies when needed. Early intervention with physical therapy, speech therapy, nutritional support, and respiratory care can help maintain function longer and prevent complications.^[13]

Pathophysiology

Understanding what happens inside the body during familial ALS requires looking at both the genetic level and the cellular changes that ultimately lead to motor neuron death. The pathophysiology, or the disordered physiological processes associated with disease, in familial ALS involves multiple interconnected mechanisms that all contribute to the progressive destruction of motor neurons.^[10]

At the most fundamental level, familial ALS begins with mutations in specific genes that are critical for normal motor neuron function. These genetic changes lead to the production of abnormal proteins that accumulate inside cells. In the case of SOD1 mutations, for instance, the mutated gene produces a misfolded version of the superoxide dismutase enzyme. These misfolded proteins clump together inside motor neurons, forming toxic aggregates that disrupt normal cellular function. This protein aggregation is thought to trigger a cascade of harmful events within the cell.^[6]

In more than ninety-five percent of ALS cases, including many familial cases, there is abnormal accumulation of a protein called TDP-43 in motor neurons. Normally, TDP-43 functions in the cell nucleus where it helps process RNA molecules. In ALS, TDP-43 leaves the nucleus and accumulates in the cytoplasm of the cell, where it forms clumps. This mislocalization and aggregation disrupts RNA processing, leading to widespread errors in how genetic information is used to make proteins. These errors, called cryptic splicing, result in the production of dysfunctional proteins that further damage motor neurons.^[2]

Motor neurons in familial ALS experience significant stress on their mitochondria, the cellular structures responsible for producing energy. Mitochondrial dysfunction impairs the cell’s ability to generate the energy needed for normal function, making neurons more vulnerable to damage and death. This energy crisis is particularly problematic for motor neurons, which have very high energy demands due to their large size and long axons that must maintain communication with distant muscles.^[2]

Another critical problem in familial ALS involves the transport system within motor neurons. These cells have extraordinarily long projections called axons that can extend from the spinal cord all the way to muscles in the hands or feet. Materials must be constantly transported back and forth along these axons to maintain the connection between the nerve cell body and the muscle. In ALS, this transport system becomes impaired, preventing essential nutrients and cellular components from reaching the parts of the neuron that need them. This leads to the axon dying back from its connection with the muscle, a process called “dying back” neuropathy.^[10]

The communication point between motor neurons and muscles, called the neuromuscular junction, deteriorates early in familial ALS. Even before motor neurons begin to die, these critical connections start to fail. When the neuromuscular junction breaks down, the motor neuron can no longer effectively signal the muscle to contract, resulting in weakness even while the neuron cell body remains alive. This early disconnection may explain why muscle weakness appears before widespread motor neuron death occurs.^[10]

Inside motor neurons affected by familial ALS, stress granules form in response to cellular stress. These are temporary structures that normally form to protect RNA during times of stress. However, in ALS, these stress granules become persistent and dysfunctional, trapping important RNA molecules and preventing them from being used to make essential proteins. This further disrupts normal cellular function and contributes to neuron death.^[10]

The normal movement of molecules between the cell nucleus and the cytoplasm becomes disrupted in familial ALS. This breakdown in nucleocytoplasmic transport prevents important regulatory proteins from reaching their proper locations within the cell. Some proteins that should be in the nucleus accumulate in the cytoplasm, while others that should be in the cytoplasm get trapped in the nucleus. This cellular confusion contributes to widespread dysfunction and eventual cell death.^[10]

Oxidative stress, an imbalance between the production of reactive oxygen species and the cell’s ability to neutralize them, plays a significant role in motor neuron damage. Reactive oxygen species are chemically active molecules that can damage cellular components including DNA, proteins, and lipids. Motor neurons in familial ALS appear particularly vulnerable to this type of damage, especially when protective mechanisms like SOD1 are compromised by mutations.^[2]

The immune system, particularly specialized immune cells in the brain and spinal cord called microglia, becomes activated in ALS. While these cells normally help protect neurons, in ALS they become overactive and may actually contribute to motor neuron damage through release of inflammatory molecules. This chronic inflammation creates a hostile environment for motor neurons and accelerates disease progression.^[2]

The death of motor neurons in familial ALS appears to involve a programmed cell death pathway called apoptosis. Rather than dying from external injury, motor neurons activate internal death programs in response to the accumulated cellular stress and damage. Once enough motor neurons die, the remaining neurons cannot compensate, and muscle weakness becomes clinically apparent. As more and more motor neurons die over time, weakness progresses throughout the body, eventually affecting the muscles needed for breathing and other vital functions.^[10]